Saturday 17 October 2026
Export GRDX’s income statement to Excel — free account
GridAI Technologies Corp.
GRDX Healthcare Biotechnology
GridAI Technologies Corp.’s revenue for fiscal 2025 (year ended December 2025) was $36,300.00. In the quarter to June 2026, EPS fell 219.0%, free cash flow fell 2,641.0% and total debt fell 64.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
4.22
0.24
−5.38%
Follow GRDX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (485.88%) | (98.16%) | (63.89%) | (88.03%) |
+8 more TTM periods Free account |
|
| (34.14%) | (13.55%) | (10.05%) | (14.43%) | ||
ROIC |
(79.29%) | (22.63%) | (15.78%) | (2.56%) | |
Return on Tangible Assets |
175.94% | 66.11% | 53.57% | (29.43%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.27) | (1.50) | (3.53) | (1.15) | |
Free Cash Flow |
(8.12) | (6.67) | (5.70) | (1.90) | |
| Other line items | |||||
Cash ROIC |
(39.81%) | (23.70%) | (19.01%) | (2.05%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.29 | 0.21 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
1,020.03 | 2,060.19 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | |
Tax Rate |
(0.50) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
— | (9.75) | (12.72) | — | |
Operating CF/Net income |
0.39 | 0.74 | 0.85 | 0.12 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.27) | (1.50) | (3.53) | (1.15) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Oct 2026